126 related articles for article (PubMed ID: 18347567)
1. Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients.
Safdar A
Bone Marrow Transplant; 2008 Apr; 41(8):707-8. PubMed ID: 18347567
[No Abstract] [Full Text] [Related]
2. Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child.
Shachor-Meyouhas Y; Ben-Barak A; Kassis I
Pediatr Blood Cancer; 2011 Aug; 57(2):350-1. PubMed ID: 21671370
[No Abstract] [Full Text] [Related]
3. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin.
Bonney D; Razali H; Turner A; Will A
Br J Haematol; 2009 Jun; 145(5):667-9. PubMed ID: 19344395
[No Abstract] [Full Text] [Related]
4. [Human metapneumovirus].
Stepánová E; Zák P; Stepánová V; Ryska P
Klin Mikrobiol Infekc Lek; 2010 Aug; 16(4):124-9. PubMed ID: 20809463
[TBL] [Abstract][Full Text] [Related]
5. Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG.
Kitanovski L; Kopriva S; Pokorn M; Dolničar MB; Rajić V; Stefanović M; Jazbec J
J Pediatr Hematol Oncol; 2013 Oct; 35(7):e311-3. PubMed ID: 23669731
[TBL] [Abstract][Full Text] [Related]
6. The human metapneumovirus: a case series and review of the literature.
Shahda S; Carlos WG; Kiel PJ; Khan BA; Hage CA
Transpl Infect Dis; 2011 Jun; 13(3):324-8. PubMed ID: 21631655
[TBL] [Abstract][Full Text] [Related]
7. Frequency of human metapneumovirus infection in hematopoietic SCT recipients during 3 consecutive years.
Oliveira R; Machado A; Tateno A; Boas LV; Pannuti C; Machado C
Bone Marrow Transplant; 2008 Aug; 42(4):265-9. PubMed ID: 18516078
[TBL] [Abstract][Full Text] [Related]
8. Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
Chakrabarti S; Collingham KE; Holder K; Oyaide S; Pillay D; Milligan DW
Clin Infect Dis; 2000 Dec; 31(6):1516-8. PubMed ID: 11096028
[TBL] [Abstract][Full Text] [Related]
9. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients.
Englund JA; Boeckh M; Kuypers J; Nichols WG; Hackman RC; Morrow RA; Fredricks DN; Corey L
Ann Intern Med; 2006 Mar; 144(5):344-9. PubMed ID: 16520475
[TBL] [Abstract][Full Text] [Related]
10. Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience.
Tsitsikas DA; Oakervee H; Cavenagh JD; Gribben J; Agrawal SG; Mattes FM
Br J Haematol; 2009 Sep; 146(5):574-6. PubMed ID: 19538531
[No Abstract] [Full Text] [Related]
11. Human metapneumovirus.
Deffrasnes C; Hamelin ME; Boivin G
Semin Respir Crit Care Med; 2007 Apr; 28(2):213-21. PubMed ID: 17458775
[TBL] [Abstract][Full Text] [Related]
12. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection.
Hamelin ME; Prince GA; Boivin G
Antimicrob Agents Chemother; 2006 Feb; 50(2):774-7. PubMed ID: 16436743
[TBL] [Abstract][Full Text] [Related]
13. Oral ribavirin for paramyxovirus infection after alemtuzumab-containing reduced-intensity conditioning HCT regimen.
Dreyzin A; Michaels MG; Vander Lugt MT; Szabolcs P
Pediatr Transplant; 2019 Mar; 23(2):e13358. PubMed ID: 30687992
[TBL] [Abstract][Full Text] [Related]
14. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation.
Egli A; Bucher C; Dumoulin A; Stern M; Buser A; Bubendorf L; Gregor M; Servida P; Sommer G; Bremerich J; Gratwohl A; Khanna N; Widmer AF; Battegay M; Tamm M; Hirsch HH; Halter JP
Infection; 2012 Dec; 40(6):677-84. PubMed ID: 22802096
[TBL] [Abstract][Full Text] [Related]
15. Serious outbreak of human metapneumovirus in patients with hematologic malignancies.
Hoellein A; Hecker J; Hoffmann D; Göttle F; Protzer U; Peschel C; Götze K
Leuk Lymphoma; 2016; 57(3):623-7. PubMed ID: 26122193
[TBL] [Abstract][Full Text] [Related]
16. Human metapneumovirus in haematopoietic stem cell transplantation recipients: a case series and review of the diagnostic and therapeutic approach.
Hoppe BP; de Jongh E; Griffioen-Keijzer A; Zijlstra-Baalbergen JM; IJzerman EP; Baboe F
Neth J Med; 2016 Oct; 74(8):336-341. PubMed ID: 27762221
[TBL] [Abstract][Full Text] [Related]
17. Human metapneumovirus: a not so new virus.
Mejías A; Chávez-Bueno S; Ramilo O
Pediatr Infect Dis J; 2004 Jan; 23(1):1-7; quiz 8-10. PubMed ID: 14743038
[No Abstract] [Full Text] [Related]
18. Respiratory viral infections in transplant recipients.
Ison MG
Antivir Ther; 2007; 12(4 Pt B):627-38. PubMed ID: 17944270
[TBL] [Abstract][Full Text] [Related]
19. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
Kim YJ; Boeckh M; Englund JA
Semin Respir Crit Care Med; 2007 Apr; 28(2):222-42. PubMed ID: 17458776
[TBL] [Abstract][Full Text] [Related]
20. Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection.
Hayden FG; Sable CA; Connor JD; Lane J
Antivir Ther; 1996 Jan; 1(1):51-6. PubMed ID: 11322259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
